PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of onclettLink to Publisher's site
 
Oncol Lett. 2012 July; 4(1): 53–57.
Published online 2012 April 27. doi:  10.3892/ol.2012.699
PMCID: PMC3398362

Gastric carcinosarcoma: A case report and review of the literature

Abstract

Carcinosarcoma of the stomach is a rare biphasic tumor that consists of both carcinomatous and sarcomatous components. The common carcinoma component is tubular or papillary adenocarcinoma and the mesenchymal sarcomatous components are variable but may include leiomyosarcoma, rhabdomyosarcoma and osteosarcoma. The aim of this study was to describe the characteristics of gastric carcinosarcoma and to present a review of the available literature. We report a case of carcinosarcoma in a 62-year-old female including the clinical and histopathological features of this tumor. Following ultrasound and computed tomography scans, laparotomy was performed, revealing a large mass, followed by radical surgery. Macroscopically, a polypoid tumor was observed. Microscopically, the tumor was composed of moderately differentiated adenocarcinoma and poorly differentiated sarcoma with a high mitotic index and necrotic areas. At present, the achievement of a definitive diagnosis is dependent on immunohistochemical staining and radical surgery. Thus, more effective diagnostic methods are required to improve patient survival.

Keywords: carcinosarcoma, gastric tumor

Introduction

Carcinosarcoma of the stomach is an extremely rare mixed tumor comprising carcinoma and sarcoma components (1). The most common carcinoma component is tubular or papillary adenocarcinoma, while neuroendocrine carcinomatous differentiation is less common. The mesenchymal sarcomatous component is variable and may include leiomyosarcoma, rhabdomyosarcoma, osteosarcoma or chondrosarcoma (2).

Tumor in the upper gastrointestinal tract tends to be localized in the esophagus where it represents approximately 3% of all esophageal tumors. By contrast, only 52 cases of gastric carcinosarcoma have been reported in the literature thus far, most of which are described in the Japanese literature (3). Other terms for this tumor are sarcomatoid carcinoma of the stomach and spindle cell carcinoma of the stomach. The average survival of these patients is 2–6 months. In the present study, we report a case of gastric carcinosarcoma and review some of the literature. Consent was obtained from the patient.

Case report

A 62 year-old woman was admitted to our division reporting a history of epigastric pain with asthenia and weight loss (8 kilos over 3 months). The physical examination revealed no specific findings. The patient underwent the following laboratory tests and endoscopic examinations: esophagogastroduodenoscopy (EGD), ultrasound (US) and computed tomography (CT) scanning. The EGD revealed an ulcerated mass in the gastric body-fundus.

On abdominal US, three hepatic mass lesions were revealed, the largest one being 5×3 cm in size. Abdominal CT revealed that the tumor had metastasized through the gastric wall up to the serose and confirmed the hepatic US report. The patient subsequently underwent an exploratory laparotomy that revealed a large mass (20×15 cm in size). The tumor had infiltrated the pancreatic body-tail, gastric body fundus, splenic hilium and left adrenal gland. A total gastrectomy with Roux-en-Y esophagojejunostomy with body-tail pancreatic resection and left surrenalectomy was performed.

Despite the poor prognosis, radical surgery was performed since the tumor had invaded most of the organ and perivisceral structures. Radiofrequency ablation (RFA) was used for the treatment of the hepatic lesions.

Macroscopically, an ulcerative polypoid tumor (13×10 cm) arising from the gastric body fundus was observed. The mass had infiltrated through all layers of the gastric wall and extended to the pancreatic tail. The spleen was not infiltrated by the tumor. Microscopically, the tumor was composed of moderately differentiated adenocarcinoma and poorly differentiated sarcoma with a high mitotic index and necrotic areas (Figs. 1 and and22).

Figure 1
The sarcomatoid component of carcinosarcoma.
Figure 2
The sarcomatoid component is on the left section of the image and the adenocarcinoma is on the right section of the image.

The carcinoma component exhibited a positive reaction to pan-cytokeratin whereas fusiform cells showed positive reactions to vimentin: HHF35; CD56; EMA (weak); desmin (singular component) and negative reactions to cytokeratin, actine, caldesmon, CD-34, S-100 and cromogranin; synaptophysin, CD-57 and c-kit. These immunohistochemical findings led to a diagnosis of gastric carcinosarcoma (Figs. 4 and and55).

Figure 4
Immunohistochemistry shows intense positivity for vimentin in the sarcomatoid component.
Figure 5
Positivity for CD-57 in the carcinomatous component.

The tumor was found to have infiltrated the perivisceral fat and peripancreatic areas. There was neoplastic vein thrombosis of the splenic hilium and, for 2 of 13 regional nodes, metastases were present (Fig. 3). These metastases belonged only to the carcinoma component (pTNM classification was: T4 N1 G3 R0). The post-operative course was unremarkable. Due to poor general health conditions, the patient did not undergo administration of chemotherapy. The patient succumbed to the disease approximately 4 months later.

Figure 3
A lymph node with metastases of the carcinomatous component.

Discussion

Carcinosarcoma is defined by the WHO as ‘a malignant tumor composed of intimately mixed epithelial and mesenchymal elements of a type ordinarily found in malignancies of adults’. This definition is based on traditional histological findings (4). The localizations of this tumor are widespread.

The most common site of origin for these tumors is the uterus. Several other organs such as the salivary gland, thyroid gland, breast, gallbladder, esophagus, stomach, small and large intestine, pancreas, urinary system and the prostate gland may also be affected by this type of tumor.

Localization in the stomach has been less frequently reported (5); male (M) gender is more affected than female (F) (M:F=2.8:1). These data are considerably different from that of other locations where localization to other sites occurs more frequently in women (i.e., gallbladder M:F=1:3.25).

The median age of patients affected by gastric carcinosarcoma was 62 years (range, 29–80), slightly lower than other localizations in which the most frequent onset age is the geriatric age (6). The youngest patient was 29 years old and this case was originally reported by Saito in 1916 [described by Ashida et al (7)], while the oldest patient was 80 years old, as reported by Ooi in 1982 (8). The median age of male and female patients was 60.9 and 61.3 years, respectively.

The dimensions of this type of tumor calculated on data from 33 reviewed cases and our case report range in size from 4 cm [Cho et al (9)] to 15 cm [Saito, described in (7)]. The median dimension of the tumors was 9 cm. According to the macroscopic pattern of growth and particularly in relation to the gastric wall, carcinosarcoma has been classified into three types (10): i) a predominantly intramural infiltration; ii) a predominantly extramural mass; iii) a predominantly intramural mass with exophytic or crater-shaped growth.

Microscopically, carcinosarcoma is classified into two types: true carcinosarcoma and false carcinosarcoma or so-called sarcomatoid carcinoma. Most of the reviewed cases were polypoid (20 cases) or ulcerated (19 cases) in appearance. This type of tumor, as with all visceral carcinomas, tends to develop rapidly, appearing similar to an endophytic polypoid mass. It can arise from all areas of the stomach. Cancer does not occur more frequently in any one area. The exact histogenesis remains controversial and remains unknown. However, some authors have proposed two hypotheses (11). The first is the biclonal origin hypothesis that supports the collision tumor theory, according to which the carcinosarcoma originates from two different tumor cell clones. The second is the monoclonal origin hypothesis, whereby the carcinosarcoma may originate from a stem cell that is capable of undergoing both epithelial and mesenchymal differentiation.

In most cases, no specific symptoms of carcinosarcoma were reported and it was the epiphenomenon of locally advanced gastric cancer: asthenia, epigastric pain, dysphagia and vomiting. However, the occurrence of hematemesis and melena were infrequent (12). A mass in the epigastric region is frequently revealed on physical examination. Endoscopic examination is the gold standard in diagnosis as is contrast-enhanced CT in the staging of the disease. However, clinical symptoms of carcinosarcomas do not differ from gastric adenocarcinomas, and a discriminating diagnosis is endoscopically or radiologically impossible. Furthermore, only an epithelial or sarcomatous component of the tumor may be observed in small endoscopic biopsies (13).

In 89% of patients a surgical procedure was performed. In most cases curative surgery was performed. In some rare cases palliative surgery was carried out to restore intestinal continuity or cytoreductive surgery to remove a mass necrosis (14).

The most frequent surgical procedure performed was total gastrectomy, which was often carried out on principle and not of necessity (the tumor had invaded the majority of the organ and/or perivisceral structures, or prior gastrectomy for peptic ulcer disease).

Splenectomy and partial pancreatectomy were not performed on principle but only as a necessity to intervene in patients with tumors that had invaded the surrounding structures. When feasible, resection of liver metastasis was performed at the same time as gastrectomy (15).

In the past, the diagnosis of carcinosarcoma was obtained by conventional histology. The first association between traditional histology and immunohistochemistry in the diagnosis of carcinosarcoma was in a case report in 1988 (16). A third neuroendocrin component has been identified in certain cases in addition to the carcinoma and sarcoma components

CEA, EMA, pancreatin, chromogranin A, CD56 and synaptophysin staining are highly specific markers used to identify carcinomatous components, whereas desmin, vimentin and α-smooth muscle/sarcomeric actin show affinity for the sarcomatous elements (17).

A differential diagnosis between GIST and mesotelioma is crucial. GIST often occurs as a large intra-abdominal tumor and sometimes consists of spindle-shaped or epithelioid cells. However, carcinosarcoma shows no immunoreactivity for CD117 or CD34 and it does not demonstrate papillary or glandular structures on H&E sections, such as those usually observed in malignant mesotheliomas. It also tests negative for mesothelial cell markers, such as calretinin.

In all reviewed cases the mean survival period was extremely poor, approximately 6.5 months excluding the four major (up to 2 years) and minor survivals (less than 30 days). There was no difference in the survival of patients with gastric cancer where the neuroendocrin component was present. Overall tumor recurrence in the first postoperative year was greater than 50%.

From the review of the literature it was not possible to identify any prognostic factor because only a few cases had a survival of longer than 12 months: i) in the case report described by Ashida et al (7), the patient survived 7 years; ii) in that by Tominaga [described in (7)], the patient survived 5 years; iii) in that by Kyogoku et al (18), the patient survived 3 years; iv) in that by Kumagai et al (19), the patient survived 2 years; v) in the one by Teramachi et al (1) the patient survived 20 months; and vi) in the case report described by Kitamura (20), the patient survived for 1 year (Table I).

Table I
Reported cases of gastric carcinosarcoma.

The most common site of recurrence is the liver where metastases occur immediately after surgery (17,21). In the present case report, liver metastases originate from the adenocarcinoma component.

In conclusion, we reported a case of carcinosarcoma and the procedure for achieving a definitive diagnosis. The simultaneous presence of epithelial and mesenchymal elements in a gastric tumor is a rare event, found almost exclusively in areas with high incidence of gastric cancer and with only few cases reported in literature. Carcinosarcoma of the stomach is a rare malignant tumor of often unclear etiology and pathogenesis. At present, the gold standard for definitive diagnosis is based on immunohistochemical staining of endoscopic biopsy or surgical findings. Radical gastrectomy is the treatment of choice when feasible even if the tumor has rapid growth and malignant potential. However, the recurrence of this type of tumor may be expected within the first postoperative year. Therefore, more effective diagnostic techniques should be identified to improve patient survival.

Acknowledgements

The authors thank Professor Angelo Sidoni and Dr Marta Sbaraglia of the Pathological Anatomy Unit, University of Perugia, for the histopathological analysis.

References

1. Teramachi K, Kanomata N, Hasebe T, Ishii G, Sugito M, Ochiai A. Carcinosarcoma (pure endocrine cell carcinoma with sarcoma components) of the stomach. Pathol Int. 2003;53:552–556. [PubMed]
2. Khan AR. Sarcomatoid carcinoma of the stomach with heterologous elements. Ann Saudi Med. 1999;19:135–136. [PubMed]
3. Solerio D, Ruffini E, Camandona M, Raggio E, Castellano I, Dei Poli M. Carcinosarcoma of the esophagogastric junction. Tumori. 2008;94:416–418. [PubMed]
4. Maiorana A, Fante R, Maria Cesinaro A, Adriana Fano R. Synchronous occurrence of epithelial and stromal tumors in the stomach: a report of 6 cases. Arch Pathol Lab Med. 2000;124:682–686. [PubMed]
5. Nakayama Y, Murayama H, Iwasaki H, Iwanaga S, Kikuchi M, Ikeda S, Okada M, Iizuka Y, Iwashita A. Gastric carcinosarcoma (sarcomatoid carcinoma) with rhabdomyoblastic and osteoblastic differentiation. Pathol Int. 1997;47:557–563. [PubMed]
6. Guerra Bautista JA, Ibáñez Delgado F, Hernández de la Torre Bustillo JM, Alcántara Gijón F. Gastric carcinosarcoma. Rev Esp Enferm Dig. 2006;98:146–147. [PubMed]
7. Ashida K, Wamata T, Sugesawa A, Miyano Y, Iwai N, Tani H. A case of so-called carcinosarcoma of the stomach. J Jpn Surg Assoc. 1998;59:702–706.
8. Ooi A, Okada Y, Nakanishi I, Nakajima Y. A case of so-called carcinosarcoma of the stomach (in Japanese) Jpn J Cancer Clin. 1982;28:1300–1304.
9. Cho KJ, Myong NH, Choi DW, Jang JJ. Carcinosarcoma of the stomach. A case report with light microscopic, immunohistochemical, and electron microscopic study. APMIS. 1990;98:991–995. [PubMed]
10. Jang SM, Jang SH, Min KW, Na W, Jun YJ, Paik SS. A case of gastric carcinosarcoma with neuroendocrine and smooth muscle differentiation. Korean J Pathol. 2010;44:87–91.
11. Randjelovic T, Filipovic B, Babic D, Cemerikic V, Filipovic B. Carcinosarcoma of the stomach: a case report and review of the literature. World J Gastroenterol. 2007;13:5533–5536. [PubMed]
12. Kuroda N, Oonishi K, Iwamura S, Ohara M, Hirouchi T, Mizumo K, Miyazaki E, Enzan H. Gastric carcinosarcoma with neuroendocrine differentiation as the carcinoma component and leiomyosarcomatous and myofibroblastic differentiation as the sarcomatous component. APMIS. 2006;114:234–238. [PubMed]
13. Kikuyama R, Tanaka K, Tano S, et al. A case of gastric carcinosarcoma. Endoscopy. 2009;41:e220–e221. [PubMed]
14. Ikeda Y, Kosugi S, Nishikura K, et al. Gastric carcinosarcoma presenting as a huge epigastric mass. Gastric Cancer. 2007;10:63–68. [PubMed]
15. Kayaselcuk F, Tuncer I, Toyganozu Y, et al. Carcinosarcoma of the stomach. Pathol Oncol Res. 2002;8:275–277. [PubMed]
16. Siegal A, Freund U, Gal R. Carcinosarcoma of the stomach. Histopathology. 1988;13:350–353. [PubMed]
17. Yamazaki K. A gastric carcinosarcoma with neuroendocrine cell differentiation and undifferentiated spindle-shaped sarcoma component possibly progressing from the conventional tubular adenocarcinoma; an immunohisto-chemical and ultrastructural study. Virchows Arch. 2003;442:77–81. [PubMed]
18. Kyogoku M, Okukubo T, Aoki S. An autopsy case of carcinosarcoma which originated in the stomach. Gann. 1960;51:278–279.
19. Kumagai K, Kawai K, Kusano H, Matsuo K, Irie J, Tsuchiyama H, Aridome Y. A case of so-called carcinosarcoma of the stomach. Gan No Rinsho. 1984;30:1931–1936. [PubMed]
20. Kitamura S. Study on carcinosarcoma of stomach. Gann. 1950;41:15–27. [PubMed]
21. Matsukuma S, Wada R, Hase K, Sakai Y, Ogata S, Kuwabara N. Gastric stump carcinosarcoma with rhabdomyosarcomatous differentiation. Pathol Int. 1997;47:73–77. [PubMed]
22. Pase F, Galassi A, Tormen D, Missaglia C, Petrelli G, D’Amore ES. Composite tumour of the stomach: a case report and review of the literature. Chir Ital. 2005;57:99–102. [PubMed]
23. Melato M, Bucconi S, Grillo BP, Angelucci D, Di Stefano P, Natoli C. Carcinosarcoma and separate neuroendocrine malignant tumor of a malignancy promoter, the gastric stump. Anticancer Res. 1993;13:2485–2488. [PubMed]
24. Tsuneyama K, Sasaki M, Sabit A, Yokoi K, Arano Y, Imai T, et al. A case report of gastric carcinosarcoma with rhabdomyosarcomatous and neuroendocrinal differentiation. Pathol Res Pract. 1999;195:93–97. discussion 8. [PubMed]
25. Cruz JJ, Paz JI, Cordero M, Martin J, del Mar Abad M. Carcinosarcoma of the stomach with endocrine differentiation. A case report. Tumori. 1991;77:355–357. [PubMed]

Articles from Oncology Letters are provided here courtesy of Spandidos Publications